Tetsuya Nishida

Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells

Keisuke Watanabe, Seitaro Terakura, Anton C. Martens et al. · The Journal of Immunology · 2014 · 285 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar et al. · Blood · 2010 · 267 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Defective Epstein–Barr virus in chronic active infection and haematological malignancy

Yusuke Okuno, Takayuki Murata, Yoshitaka Sato et al. · Nature Microbiology · 2019 · 241 citations

Life Sciences, Hematology, Microbiology +15

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group

Katsuto Takenaka, Tetsuya Nishida, Yuki Asano‐Mori et al. · Biology of Blood and Marrow Transplantation · 2015 · 194 citations · Full text

Medicine, Hematology, Immunology +15

Identification and molecular characterization of an <i>N</i>‐acetylmuramyl‐<scp>l</scp>‐alanine amidase Sle1 involved in cell separation of <i>Staphylococcus aureus</i>

Junko Kajimura, Tamaki Fujiwara, Sakuo Yamada et al. · Molecular Microbiology · 2005 · 181 citations

Life Sciences, Microbiology, Molecular Biology +15